GI Oncology Multidisciplinary Conference and Tumor Board
February 25, 2015
1:30 pm – 2:30 pm
2 West PCAM Conference Room
Edgar Ben-Josef and Ursina Teitelbaum
Hospital of the University of Pennsylvania: Abramson Cancer Center
3400 Civic Center Blvd.
Target Audience
This program has been designed for departmental/institutional faculty, fellows, residents, medical students, nurses, allied health professionals, social workers, and dieticians in the medical specialties of medical oncology, radiation oncology, surgical oncology, pathology and radiology.
Educational Objectives
After completing this activity, participants should be able to:
· Construct, formulate and better communicate a cohesive plan of management for patient care
· Provide multidisciplinary approach to patient care
· Improve adherence to practice guidelines and the practice of evidence-based medicine
· Reduce variations in the delivery of patient care
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Lauren White
215-615-0581
xx
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Planning Committee Member & Presenter Name
Edgar Ben-Josef, MD / Ursina Teitelbaum, MD / James Metz, MDPresenter Name
Loretta Cavalere / Nevena Damjanov / Erin L. Davis, MSN, CRNP / Tracey D’entremont / Trish GambinoJenna Gates / Katie Green / Mona S. Jacobs-Small, CCRC / Suzanne McGettigan / Mark O’Hara
Eric Ojerholm / John Plasteras / Evan Siegelman / Andrea Strouth / Charles Vollmer, Jr.
Valaree Williams / Rimini varghese / Arturo loaiza-bonilla / James Metz / Et-Tsu Chen
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
Presenter Name Name of Commercial Interest Relationship
Jeffrey Drebin, MD Roche/Genentech Royalty
Elizabeth Preichtel Dunphy, CRNP Bayer, Celgene Speaker Honorarium
Paul Wissel, MD Glaxo Smith Kline Salary/Stock Option
Gregory L. Beatty Incyte, US Oncology, World Health Comm, Janssen, GSK Honorarium
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected
Disclosure of Unapproved Uses of Products
Presenter name Product Investigational and/or Off-label Use